Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

COVID-19 and modern pediatric practice

DOI: https://doi.org/10.29296/25879979-2021-02-03
Download full text PDF
Issue: 
2
Year: 
2021

L.A. Kharitonova(1), O.N. Solodovnikova(1), A.A. Ploskireva(1,2), T.V. Sbrodova(1), K.I. Grigoriev(1) 1-N.I. Pirogov Russian National Research Medical University, Russian Health Ministry; 2-Central Research Institute of Epidemiology, Federal Service on Customers’ Rights Protection and Human Well-being Surveillance

The pandemic of a new severe infection, announced by the World Health Organization last year, continues to develop. To a certain extent, the epidemic has affected the child population. For the first time, pediatricians are faced with the incredible situation where adults are more severely ill than children. However, children were not left out of the spread of COVID-19. The article summarizes the results of developments concerning the development of a new disease, its diagnosis, therapeutic possibilities with the use of modern medicines. Most of the information regarding the impact of the novel coronavirus on children is still in clinical trials and is on the way to being introduced into pediatric practice.
Keywords: 
children
COVID-19
SARS-CoV-2
clinical features
prevention
“red” zone

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Babanov S.A., Shtejner M.L., Biktagirov Ju.I., Zhestkov A.V., Strizhakov L.A., Ostrjakova N.A., Agarkova A.S., Kirjushina T.M. Potentsial'nye epidemicheskie riski i ih uchet pri provedenii endoskopicheskih issledovanij v uslovijah COVID-gospitalja. Vrach, 2021; 2 (32): 47-52 https://doi.org/10.29296/25877305-2021-02-09
  2. Gomi R., Asgari N., Hadzhihejdari A., Esteki R., Bajbanaki F., Nasirinasab F. Pandemija COVID-19: sistematicheskij obzor sovremennyh dannyh. Infektsija i immunitet. 2020;10(4):655-663.https://doi.org/ 10.15789/2220-7619-TCP-1508
  3. Kaleda M.I., Nikishina I.P., Fedorov E.S., Nasonov E.L. Koronavirusnaja bolezn' 2019 (COVID-19) u detej: uroki pediatricheskoj revmatologii. Nauchno-prakticheskaja revmatologija. 2020;58(5):469-479. https://doi.org/10.47360/1995-4484-2020-469-479
  4. Ministerstvo zdravoohranenija RF. Metodicheskie rekomendatsii: Osobennosti klinicheskih projavlenij i lechenija zabolevanija, vyzvannogo novoj koronavirusnoj infektsiej (COVID-19) u detej. Versija 2 (03.07.2020). Dostupno na: https://static-0.minzdrav.gov.ru/ system/attachments/attaches/000/050/914/original/03062020_%D0%B4%D0%B5%D1%82%D0%B8_COVID-19_v2.pdf
  5. Mul'tisistemnyj vospalitel'nyj sindrom u detej (MIS-C) [internet]. (CDC (2020) Tsentry po kontrolju i profilaktike zabolevanij. https://www.cdc.gov/mis-c/hcp/
  6. Namazova-Baranova L.S., Baranov A.A. COVID-19 i deti. Pul'monologija. 2020; 30 (5): 609–628. DOI: 10.18093/0869-0189-2020-30-5-609-628
  7. Pimanov S.I., Dikareva E.A. Gastroentero-logicheskie projavlenija COVID-19: pervye obobschenija. Klinicheskij razbor v obschej meditsine. 2020; 1: 6-13. DOI: 10.47407/kr2020.1.1.00001
  8. Samorodskaja I.V. Problemy vybora metodov lechenija. Vrach, 2020; 8 (31): 11-18 https://doi.org/10.29296/25877305-2020-08-02
  9. Furman E.G. Koronavirusnaja infektsija COVID-19 i deti. Pediatrija im. G.N. Speranskogo. 2020; 99 (3): 245-251.
  10. Cai J., Xu J., Lin D. et al. A case series of children with 2019 novel coronavirus infection: Clinical and epidemiological features. Clin. Infect. Dis. 2020; 71 (6): 1547–1551. DOI: 10.1093/cid/ciaa198.
  11. Sao V., Wang Y., Wen D. et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med. 2020; 382 (19): 1787–1799. DOI: 10.1056/NEJMoa2001282
  12. Diez J.-M., Romero C., Gajardo R. Currently available intravenous immunoglobulin (Gamunex®-C and Flebogamma® DIF) contains antibodies reacting against SARS-CoV-2 antigens. bioRxiv. 2020: 029017. DOI: 10.1101/2020.04.07.029017
  13. Drexler J.F., Gloza-Rausch F., Glende J., Corman V.M., Muth D., Goettsche M./Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences. J Virol. 2010; 84(21):11336-49. doi: 10.1128/JVI.00650-10. Epub 2010 Aug 4.
  14. Feldstein LR, Rose EB, Horwitz SM, Collins JP,Newhams MM, Son MBF idr. Mul'tisistemnyj vospalitel'nyj sindrom u detej i podrostkov SShA. N Engl J Med. 2020;383(4):334–346. doi: 10.1056/NEJMoa2021680.
  15. Grein J., Ohmagari N., Shin D. et al. Compassionate use of remdesivir for patients with severe COVID-19. N Engl J Med. 2020; 382 (24): 2327–2336. DOI: 10.1056/NEJMoa2007016
  16. Hamre D., Procknow J.J. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 1966; 121(1):190-3. doi: 10.3181/00379727-121-30734
  17. Liang W., Feng Z., Rao S., Xiao C., Xue X., Lin Z., Zhang Q., Qi W. Diareja mozhet byt' nedootsenena: nedostajuschee zveno v novom koronaviruse 2019 goda. Gut. 2020; 69:1141–1143.
  18. Rojas M., Rodriguez Y., Monsalve D.M., et al. Convalescent plasma in Covid-19: Possible mechanisms of action. Autoimmun Rev. 2020; 19(7):102554. DOI: 10.1016/j.autrev.2020.102554
  19. Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019; 11(1): 59. doi: 10.3390/v11010059
  20. Van der Hoek L., Pyrc K., Jebbink M.F., Vermeulen-Oost W., Berkhout R.J., Wolthers K.C. Identification of a new human coronavirus. Nat Med. 2004; 10(4): 368-73. doi: 10.1038/nm1024. Epub 2004 Mar 21.
  21. Van Doremalen N., Bushmaker T., Morris D.H. et al. Aerosol and surface stability of Sars-Cov-2 as compared with Sars-Cov-1. N Engl J Med. 2020; 382 (16): 1564–1567. DOI: 10.1056/NEJMc2004973
  22. WHO. Multisystem inflammatory syndrome in children and adolescents with COVID-19. URL: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 (Date accessed: 2020).
  23. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3
  24. Zou L., Ruan F., Huang M. et al. Sars-Cov-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020; 382 (12): 1177–1179. DOI: 10.1056/NEJMc 2001737
  25. Zhu H., Wang L., Fang C. et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl. Pediatr. 2020; 9 (1): 51–60. DOI: 10.21037/tp.2020.02.06.